Currently, some efforts are being made in the development of selective α-synuclein PET tracers, despite numerous obstacles in visualizing intracellular α-synuclein inclusions in synucleinopathies, including intracellular localization α-synuclein, low abundance of α-synuclein within brain [90, 91]. This evidence concerns the gene SNCA and synucleinopathy.